As of 2026-01-17, the Relative Valuation of BioXcel Therapeutics Inc (BTAI) is (52.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.84 USD, the upside of BioXcel Therapeutics Inc based on Relative Valuation is -2973.1%.
The range of the Relative Valuation is (40.48) - (63.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 20.2x | 16.8x |
| Forward P/E multiples | 13.0x - 24.8x | 17.1x |
| Fair Price | (40.48) - (63.13) | (52.87) |
| Upside | -2300.2% - -3530.8% | -2973.1% |
| Date | P/E |
| 2026-01-12 | -0.65 |
| 2026-01-09 | -0.64 |
| 2026-01-08 | -0.64 |
| 2026-01-07 | -0.65 |
| 2026-01-06 | -0.56 |
| 2026-01-05 | -0.57 |
| 2026-01-02 | -0.55 |
| 2025-12-31 | -0.51 |
| 2025-12-30 | -0.49 |
| 2025-12-29 | -0.50 |
| 2025-12-26 | -0.53 |
| 2025-12-24 | -0.55 |
| 2025-12-23 | -0.55 |
| 2025-12-22 | -0.56 |
| 2025-12-19 | -0.55 |
| 2025-12-18 | -0.59 |
| 2025-12-17 | -0.58 |
| 2025-12-16 | -0.60 |
| 2025-12-15 | -0.60 |
| 2025-12-12 | -0.64 |
| 2025-12-11 | -0.66 |
| 2025-12-10 | -0.70 |
| 2025-12-09 | -0.68 |
| 2025-12-08 | -0.71 |
| 2025-12-05 | -0.66 |
| 2025-12-04 | -0.67 |
| 2025-12-03 | -0.61 |
| 2025-12-02 | -0.60 |
| 2025-12-01 | -0.66 |
| 2025-11-28 | -0.72 |
| 2025-11-26 | -0.67 |
| 2025-11-25 | -0.61 |
| 2025-11-24 | -0.63 |
| 2025-11-21 | -0.61 |
| 2025-11-20 | -0.57 |
| 2025-11-19 | -0.56 |
| 2025-11-18 | -0.59 |
| 2025-11-17 | -0.59 |
| 2025-11-14 | -0.52 |
| 2025-11-13 | -0.52 |
| 2025-11-12 | -0.55 |
| 2025-11-11 | -0.65 |
| 2025-11-10 | -0.62 |
| 2025-11-07 | -0.59 |
| 2025-11-06 | -0.57 |
| 2025-11-05 | -0.60 |
| 2025-11-04 | -0.60 |
| 2025-11-03 | -0.61 |
| 2025-10-31 | -0.66 |
| 2025-10-30 | -0.65 |